
12/12/2024
New paper demonstrating intestinal barrier repair function in multiple preclinical models by a novel PHD1/2 inhibitor designed using generative AI to be gut restricted.
Generative artificial intelligence is used to design an effective treatment for inflammatory bowel disease in preclinical models.